Perkins Capital Management Inc. trimmed its stake in Tactile Systems Technology, Inc. (NASDAQ:TCMD – Free Report) by 9.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 62,450 shares of the company’s stock after selling 6,550 shares during the quarter. Perkins Capital Management Inc.’s holdings in Tactile Systems Technology were worth $1,070,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also made changes to their positions in the company. Rhumbline Advisers grew its stake in Tactile Systems Technology by 1.6% in the 4th quarter. Rhumbline Advisers now owns 38,033 shares of the company’s stock worth $651,000 after acquiring an additional 581 shares during the period. SG Americas Securities LLC boosted its holdings in shares of Tactile Systems Technology by 12.7% during the fourth quarter. SG Americas Securities LLC now owns 12,032 shares of the company’s stock worth $206,000 after purchasing an additional 1,354 shares during the last quarter. Principal Financial Group Inc. grew its position in shares of Tactile Systems Technology by 9.9% in the fourth quarter. Principal Financial Group Inc. now owns 20,401 shares of the company’s stock valued at $349,000 after purchasing an additional 1,836 shares during the period. Jones Financial Companies Lllp acquired a new position in Tactile Systems Technology in the fourth quarter valued at $39,000. Finally, Tidal Investments LLC lifted its position in Tactile Systems Technology by 20.9% during the third quarter. Tidal Investments LLC now owns 25,957 shares of the company’s stock worth $379,000 after buying an additional 4,483 shares during the period. 83.43% of the stock is currently owned by hedge funds and other institutional investors.
Tactile Systems Technology Price Performance
Shares of Tactile Systems Technology stock opened at $13.29 on Monday. The business’s fifty day moving average price is $15.89 and its 200 day moving average price is $15.82. Tactile Systems Technology, Inc. has a twelve month low of $11.12 and a twelve month high of $21.10. The company has a current ratio of 4.36, a quick ratio of 3.80 and a debt-to-equity ratio of 0.11. The stock has a market capitalization of $313.44 million, a P/E ratio of 18.99 and a beta of 1.24.
Insider Activity at Tactile Systems Technology
In other news, VP Kristie Burns sold 4,830 shares of the firm’s stock in a transaction on Monday, February 24th. The shares were sold at an average price of $14.65, for a total value of $70,759.50. Following the transaction, the vice president now owns 84,008 shares of the company’s stock, valued at approximately $1,230,717.20. This trade represents a 5.44 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Daniel L. Reuvers sold 10,938 shares of Tactile Systems Technology stock in a transaction on Monday, February 24th. The shares were sold at an average price of $14.55, for a total transaction of $159,147.90. Following the transaction, the director now owns 242,942 shares in the company, valued at $3,534,806.10. The trade was a 4.31 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 19,546 shares of company stock worth $285,444. Company insiders own 0.96% of the company’s stock.
Wall Street Analyst Weigh In
Several analysts have commented on TCMD shares. StockNews.com upgraded Tactile Systems Technology from a “buy” rating to a “strong-buy” rating in a report on Friday. B. Riley downgraded shares of Tactile Systems Technology from a “buy” rating to a “neutral” rating and lowered their target price for the company from $23.00 to $18.00 in a report on Wednesday, February 19th.
Get Our Latest Research Report on Tactile Systems Technology
About Tactile Systems Technology
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Featured Stories
- Five stocks we like better than Tactile Systems Technology
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- Consumer Staples Stocks, Explained
- 3 ETFs to Ride the VIX Surge During Market Volatility
- Top Stocks Investing in 5G Technology
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Want to see what other hedge funds are holding TCMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tactile Systems Technology, Inc. (NASDAQ:TCMD – Free Report).
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.